Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate
- PMID: 19075223
- PMCID: PMC2603259
- DOI: 10.1073/pnas.0805133106
Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate
Abstract
Under most conditions, resorbed bone is nearly precisely replaced in location and amount by new bone. Thus, it has long been recognized that bone loss through osteoclast-mediated bone resorption and bone replacement through osteoblast-mediated bone formation are tightly coupled processes. Abundant data conclusively demonstrate that osteoblasts direct osteoclast differentiation. Key questions remain, however, as to how osteoblasts are recruited to the resorption site and how the amount of bone produced is so precisely controlled. We hypothesized that osteoclasts play a crucial role in the promotion of bone formation. We found that osteoclast conditioned medium stimulates human mesenchymal stem (hMS) cell migration and differentiation toward the osteoblast lineage as measured by mineralized nodule formation in vitro. We identified candidate osteoclast-derived coupling factors using the Affymetrix microarray. We observed significant induction of sphingosine kinase 1 (SPHK1), which catalyzes the phosphorylation of sphingosine to form sphingosine 1-phosphate (S1P), in mature multinucleated osteoclasts as compared with preosteoclasts. S1P induces osteoblast precursor recruitment and promotes mature cell survival. Wnt10b and BMP6 also were significantly increased in mature osteoclasts, whereas sclerostin levels decreased during differentiation. Stimulation of hMS cell nodule formation by osteoclast conditioned media was attenuated by the Wnt antagonist Dkk1, a BMP6-neutralizing antibody, and by a S1P antagonist. BMP6 antibodies and the S1P antagonist, but not Dkk1, reduced osteoclast conditioned media-induced hMS chemokinesis. In summary, our findings indicate that osteoclasts may recruit osteoprogenitors to the site of bone remodeling through SIP and BMP6 and stimulate bone formation through increased activation of Wnt/BMP pathways.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
TGF-β induces Wnt10b in osteoclasts from female mice to enhance coupling to osteoblasts.Endocrinology. 2013 Oct;154(10):3745-52. doi: 10.1210/en.2013-1272. Epub 2013 Jul 16. Endocrinology. 2013. PMID: 23861379 Free PMC article.
-
Hdac3 regulates bone modeling by suppressing osteoclast responsiveness to RANKL.J Biol Chem. 2020 Dec 18;295(51):17713-17723. doi: 10.1074/jbc.RA120.013573. J Biol Chem. 2020. PMID: 33454009 Free PMC article.
-
Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation.J Clin Invest. 2013 Feb;123(2):666-81. doi: 10.1172/JCI64840. Epub 2013 Jan 16. J Clin Invest. 2013. PMID: 23321671 Free PMC article.
-
Sphingosine-1-phosphate signaling controlling osteoclasts and bone homeostasis.Biochim Biophys Acta. 2013 Jan;1831(1):223-7. doi: 10.1016/j.bbalip.2012.06.002. Epub 2012 Jun 9. Biochim Biophys Acta. 2013. PMID: 22691949 Review.
-
Molecular mechanisms in coupling of bone formation to resorption.Crit Rev Eukaryot Gene Expr. 2009;19(1):73-88. doi: 10.1615/critreveukargeneexpr.v19.i1.40. Crit Rev Eukaryot Gene Expr. 2009. PMID: 19191758 Review.
Cited by
-
Engineering bone tissue substitutes from human induced pluripotent stem cells.Proc Natl Acad Sci U S A. 2013 May 21;110(21):8680-5. doi: 10.1073/pnas.1301190110. Epub 2013 May 7. Proc Natl Acad Sci U S A. 2013. PMID: 23653480 Free PMC article.
-
Osteoclast depletion with clodronate liposomes delays fracture healing in mice.J Orthop Res. 2017 Aug;35(8):1699-1706. doi: 10.1002/jor.23440. Epub 2016 Oct 6. J Orthop Res. 2017. PMID: 27653179 Free PMC article.
-
From the Mind to the Spine: The Intersecting World of Alzheimer's and Osteoporosis.Curr Osteoporos Rep. 2024 Feb;22(1):152-164. doi: 10.1007/s11914-023-00848-w. Epub 2024 Feb 9. Curr Osteoporos Rep. 2024. PMID: 38334917 Free PMC article. Review.
-
Increased bone mass but delayed mineralization: in vivo and in vitro study for zoledronate in bone regeneration.BMC Oral Health. 2024 Sep 27;24(1):1146. doi: 10.1186/s12903-024-04906-2. BMC Oral Health. 2024. PMID: 39334089 Free PMC article.
-
Nuclear receptors in bone physiology and diseases.Physiol Rev. 2013 Apr;93(2):481-523. doi: 10.1152/physrev.00008.2012. Physiol Rev. 2013. PMID: 23589826 Free PMC article. Review.
References
-
- Khosla S. Minireview: The OPG/RANKL/RANK system. Endocrinology. 2001;142:5050–5055. - PubMed
-
- Martin TJ, Sims NA. Osteoclast-derived activity in the coupling of bone formation to resorption. Trends Mol Med. 2005;11:76–81. - PubMed
-
- Karsdal MA, Martin TJ, Bollerslev J, Christiansen C, Henriksen K. Are nonresorbing osteoclasts sources of bone anabolic activity? J Bone Miner Res. 2007;22:487–494. - PubMed
-
- Kornak U, et al. Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell. 2001;104:205–215. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
